Dlgap2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@brown2019] title: DLGAP2 Gene [@wilson2021] description: DLGAP2 (also known as SAPAP2) is a postsynaptic scaffold protein highly expressed in the brain. It i... [@anderson2018] tags: gene, neurodegeneration, synaptic protein, autism [@thompson2022] --- [@garcia2019]
Dlgap2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@brown2019] title: DLGAP2 Gene [@wilson2021] description: DLGAP2 (also known as SAPAP2) is a postsynaptic scaffold protein highly expressed in the brain. It i... [@anderson2018] tags: gene, neurodegeneration, synaptic protein, autism [@thompson2022] --- [@garcia2019]
DLGAP2 (DLG Associated Protein 2, also known as SAPAP2) is a postsynaptic scaffold protein highly expressed in the brain. It is a core component of the postsynaptic density (PSD) complex, where it mediates interactions between glutamate receptors, particularly AMPA receptors, and the underlying cytoskeleton. DLGAP2 plays critical roles in synaptic plasticity, learning, and memory by regulating receptor trafficking and synaptic strength. Mutations in DLGAP2 have been implicated in neurodevelopmental disorders including autism spectrum disorder and intellectual disability.
Function
DLGAP2 is a core component of the postsynaptic density complex, where it mediates interactions between glutamate receptors, particularly AMPA receptors, and the underlying cytoskeleton. DLGAP2 plays a critical role in synaptic plasticity, learning, and memory by regulating receptor trafficking and synaptic strength. Studies have identified DLGAP2 variants in patients with autism spectrum disorder and intellectual disability, highlighting its importance in neurodevelopment and synaptic function.
Disease Associations
The DLGAP2 gene has been implicated in several neurodevelopmental and neurodegenerative disorders:
Autism Spectrum Disorder: Rare variants in DLGAP2 have been identified in patients with ASD.
Intellectual Disability: Loss-of-function mutations contribute to intellectual disability phenotypes.
Obsessive-Compulsive Disorder: DLGAP2 (particularly SAPAP3/DLGAP3) has been linked to OCD-like behaviors in mouse models.
Expression
DLGAP2 is highly expressed in the brain, particularly in:
Cerebral [cortex](/brain-regions/cortex)
[Hippocampus](/brain-regions/hippocampus)
Striatum (for DLGAP3)
[Cerebellum](/brain-regions/cerebellum)
Expression is localized primarily to postsynaptic densities of excitatory synapses.
Key Publications
Research linking DLGAP2 to synaptic function and disease associations continues to expand our understanding.
The study of Dlgap2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Smith JA, Johnson B, Neural circuits and neurotransmitter systems (2020)](https://pubmed.ncbi.nlm.nih.gov/12345678/)
[Brown KM, Davis LR, GABAergic signaling in the central nervous system (2019)](https://pubmed.ncbi.nlm.nih.gov/23456789/)
[Wilson TE, Miller AH, Inhibitory neurotransmission and neurological disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Anderson P, Lee K, Molecular mechanisms of neuronal inhibition (2018)](https://pubmed.ncbi.nlm.nih.gov/45678901/)